The Stem Cell Blog – Page 84

Flow of cerebrospinal fluid regulates neural stem cell division – EurekAlert (press release)

2018-05-18 Michael Zand NEWS

Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting – Nasdaq

Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT MeetingNasdaq"As a leader in gene therapy for MPS IIIA patients, we feel encouraged by the strong data demonstrated thus far in this trial, showin… Continue reading

2018-05-18 Michael Zand NEWS

Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting – GlobeNewswire (press release)

Voice Of AnalystsAbeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT MeetingGlobeNewswire (press release)Each subject received a single intravenous injection of the gene therapy for systemic delivery of … Continue reading

2018-05-18 Michael Zand NEWS

New Gene Therapy Company To Focus On Lentiviral Platforms – Pharmaceutical Processing

New Gene Therapy Company To Focus On Lentiviral PlatformsPharmaceutical ProcessingBiotech company Vectalys has merged with FlashCell, a developer of non-integrating lentiviral delivered RNA treatments, to form Flash Therapeutics, a new privately held c… Continue reading

2018-05-18 Michael Zand NEWS

Homology Medicines Presents Data from PKU Gene Therapy Program Demonstrating Long-Term Durability of … – PR Newswire (press release)

Homology Medicines Presents Data from PKU Gene Therapy Program Demonstrating Long-Term Durability of …PR Newswire (press release)BEDFORD, Mass., May 18, 2018 /PRNewswire/ — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announ… Continue reading

2018-05-18 Michael Zand NEWS

uniQure Presents Preclinical Data Demonstrating Advances in the Distribution of Gene Therapy – Nasdaq

Macon DailyuniQure Presents Preclinical Data Demonstrating Advances in the Distribution of Gene TherapyNasdaqPreclinical Data Presented at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting in Chicago –. LEXINGTON, Mass. and … Continue reading

2018-05-18 Michael Zand NEWS

uniQure Presents Preclinical Data Demonstrating Advances in the … – GlobeNewswire (press release)

uniQure Presents Preclinical Data Demonstrating Advances in the …GlobeNewswire (press release)… — Preclinical Data Presented at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting in Chicago –. LEXINGTON, Mass. and AMSTERDAM,&n… Continue reading

2018-05-18 Michael Zand NEWS

Eli Lilly Acquires Pegilodecakin, Potential Immunotherapy Now in Phase 3 Trial – Immuno-Oncology News

Immuno-Oncology NewsEli Lilly Acquires Pegilodecakin, Potential Immunotherapy Now in Phase 3 TrialImmuno-Oncology NewsEli Lilly announced that it is acquiring ARMO BioSciences and its lead treatment candidate pegilodecakin (AM0010), an investigational … Continue reading

2018-05-18 Michael Zand NEWS

1
…
82
83
84
85
86
…
2,487

EurekAlert (press release)

Flow of cerebrospinal fluid regulates neural stem cell division
EurekAlert (press release)
Stem cells in the brain can divide and mature into neurons participating in various brain functions, including memory. In a paper published in the journal ‘Cell Stem Cell‘, scientists at Helmholtz Zentrum München and Ludwig-Maximilians-Universität …

Login

Cart

Tag Archives: The Stem Cell Blog

Flow of cerebrospinal fluid regulates neural stem cell division – EurekAlert (press release)

Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting – Nasdaq

Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting – GlobeNewswire (press release)

New Gene Therapy Company To Focus On Lentiviral Platforms – Pharmaceutical Processing

Homology Medicines Presents Data from PKU Gene Therapy Program Demonstrating Long-Term Durability of … – PR Newswire (press release)

uniQure Presents Preclinical Data Demonstrating Advances in the Distribution of Gene Therapy – Nasdaq

uniQure Presents Preclinical Data Demonstrating Advances in the … – GlobeNewswire (press release)

Eli Lilly Acquires Pegilodecakin, Potential Immunotherapy Now in Phase 3 Trial – Immuno-Oncology News